August 2021: Good Pharma Scorecard 2021

The Good Pharma Scorecard is an initiative by the Bioethics International organization that ranks companies and new medicines on their clinical trial transparency and data-sharing performance, taking into account ethics and legal standards. This scorecard is published by Bioethics International every two years.

The Good Pharma Scorecard for 2021 is now available on their website. The companies with a 100% transparency score, for their clinical trial transparency, with the first ranking on the scorecard are AbbVie, Amgen, Bayer, Merck KGaA / EMD Serono, Novartis, Roche / Genentech, and Takeda. Under the data sharing section companies with a 100% data sharing score are AbbVie, Amgen, AstraZeneca, Bayer, Johnson & Johnson / Janssen, Merck KGaA / EMD Serono, Novartis, Novo Nordisk, Roche / Genentech, Shire, and Takeda.



Leave a Reply